'Biohacker' Who Injected Himself with DIY Herpes Treatment Found Dead
The CEO of a biomedical startup who sparked controversy when he injected himself with an untested herpes treatment in front of a live audience in February has died, according to an email sent to Live Science.
Aaron Traywick, the CEO of Ascendance Biomedical, was found dead at 11:30 a.m. ET on Sunday (April 29) in a spa room in Washington, D.C., according to a statement provided to Live Science by the Metropolitan Police Department (MPD) of the District of Columbia. Traywick was 28 years old.
According to the website News2Share.com, Traywick was found in a flotation tank. Flotation tanks are soundproof pods filled with body-temperature saltwater that are used to promote "sensory deprivation."
The MDP is still investigating Traywick's death, though they note that at this point, they have no evidence suggesting foul play.
Traywick made news in October 2017, when he staged a live demonstration of a purported gene-therapy treatment for HIV, Live Science previously reported. The untested treatment was given to a volunteer named Tristan Roberts who has HIV; Roberts said that one month after the injection, his viral load had risen, not fallen. [11 Surprising Facts About the Immune System]
Shortly after that demonstration, the U.S. Food and Drug Administration (FDA) issued a warning about using untested gene therapies, which read, in part, "FDA is aware that gene therapy products intended for self-administration and 'do it yourself' kits to produce therapies for self-administration are being made available to the public. The sale of these products is against the law. FDA is concerned about the safety risks involved."
Traywick and Roberts skirted this law, however, through self-experimentation — they weren't selling the products.
Sign up for the Live Science daily newsletter now
Get the world’s most fascinating discoveries delivered straight to your inbox.
New2Share's Ford Fischer sat down for an interview with Traywick in early February.
Originally published on Live Science.